Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: A long-term evaluation

Therapeutic Apheresis

Volumn 3, Issue 3, 1999, Pages 203-208

  Richter, Werner O ^a,b   Donner, Markus G ^a   Schwandt, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Institute for Lipid Metabolism and Hemorheology   (Germany)

Author keywords

Atherosclerosis; Coronary lesions; Hypercholesterolemia; Low density lipoprotein apheresis

Indexed keywords

DEXTRAN SULFATE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEART INFARCTION; HUMAN; IMMUNOADSORPTION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LONG TERM CARE; MALE; PRECIPITATION; PRIORITY JOURNAL; SUDDEN DEATH; TECHNIQUE;

BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DEXTRAN SULFATE; EVALUATION STUDIES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032790486     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00154.x     Document Type: Article

References (20)

1. Stoffel W, Greve V, Borberg H. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981;2:1005-7
2. Hombach V, Borberg H, Gadzkowski A, Oette K, Stoffel W. Regression der Koronarsklerose bei familiärer Hypercholesterolämie IIa durch spezifische LDL-Apherese. Dtsch Med Wochenschr 1986;111:1709-15
3. Eisenhauer T, Armstrong VW, Wieland H, Fuchs C, Scheler F, Seidel D. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system. Klin Wochenschr 1987;65:161-8.
4. Seidel D, Armstrong VW, Schuff-Werner P, for the HELP Study Group. The HELP-LDL-Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. Eur J Clin Invest 1991;21:375-83.
5. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takeda S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regeneration unit (LDL-continuous apheresis). Atherosclerosis 1987;68:19-25.
6. Homma Y, Mikami Y, Tamachi H, Nakaya N, Nakamna A, Araki G. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis. Atherosclerosis 1986;60:23-7.
7. Bosch T. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: In vitro, ex vivo, and first clinical results. Artif Organs 1996;20:344-5.
8. Bosch T, Schmidt B, Kleophas W, Gillen C, Otto V, Passlick-Deetjen J, Gurland HJ. LDL hemoperfusion - a new procedure for LDL apheresis: First clinical application of an LDL adsorber compatible with human whole blood. Artif Organs 1997;21:977-82.
9. Richter WO, Jacob BG, Ritter MM, Sühler K, Vierneisel K, Schwandt P. 3-year treatment of familial heterozygous hypercholesterolemia by extracorporeal LDL-immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 1993;42:888-94.
10. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
11. Richter WO, Donner MG, Höfling B, Schwandt P. Long-term effect of low density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia. Metabolism 1998;47:863-8.
12. Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC, Dinsenbacher A, Eisenhauer T, Grützmacher P, Keller C, Kettner U, Kleophas, Köster W, Olbricht CJ, Richter WO, Seidel D, the HELP Study Group. The HELP-LDL-Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994;24:724-32.
13. Tatami R, Inoue N, Itho H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi, Yamamoto A, Goto Y for the LARS Investigators. Regression of coronary atherosclerosis by combined LDL apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. Atherosclerosis 1992;95: 1-13.
14. Thompson GR, Maher VM, Matthews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, de Feyter P, Henderson A. Familial Hypercholesterolaemia Regression Study: A randomized trial of low-density-lipoprotein apheresis. Lancet 1995;345:811-6.
15. Kroon AA, Aengevearen WRM, van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG, Stalenhof AFH. The LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996;93: 1826-35.
16. Borberg H, Oette K. Experience with and conclusions from three different trials on low density lipoprotein apheresis. In: Agishi T, Kawamura A, Mineshima M, eds. Therapeutic plasmapheresis (XII). Utrecht: VSP, 1993;25-8.
17. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4 S). Lancet 1994;344:1383-89.
18. Kojima S, Harada-Shiba M, Toyota Y, Kimura G, Tsushima H, Kuramochi M, Sakata T, Uchida K, Yamamoto A, Omae T. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Artif Organs 1992;15:185-90.
19. Richter WO, Selmair A, Schwandt P. Coagulation factors and parameters before and after extracorporeal LDL apheresis by dextran sulfate adsorption, [abstract]. Xth Int Symp on Atherosclerosis, Montreal, 1994:317.
20. Richter WO, Jacob B, Ritter MM, Sühler K, Vierneisel K, Schwandt P. Treatment of severe hypercholesterolemia with heparin-induced LDL apheresis. Curr Ther Res 1992;52: 317-329.